The latest news from ASH 2024 focused on mantle cell lymphoma (MCL) including abstracts, features, and helpful conference information.
Luis Sumoza, MD, highlights the need to explain the disease, its consequences, and treatment side effects to patients, highlighting effective communication with primary care providers is crucial to ensure coordinated care.
Early palliative care improves transplant patients' quality of life, especially for minoritized groups or those with high distress, suggesting targeted or clinician-led care.
Physician's Weekly spoke with Alexey Danilov, MD, PhD, at ASH 2024 on personalized care and prognostic insights in CLL.
Educational programs and psychological support addressing cancer-related beliefs and promoting healthier coping strategies are crucial for improving outcomes.
According to data from the 66th ASH Annual Meeting, advancements in the treatment of relapsed/refractory mantle cell lymphoma (R/R MCL) have introduced novel therapies such as BTK inhibitors.
Insights from the leaders in medical research, trending topics in clinical medicine, and perspectives from your colleagues.
Subscribe to our free Newsletters to receive weekly emails, and even get a laugh or two from our medical cartoons.
